BCLI stock

Brainstorm Cell Therapeutics Inc (BCLI) financials · $11.4M cap

Brainstorm Cell Therapeutics Inc (BCLI) $11.4M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$10.0M-$11.7M
Net Income-$10.3M-$11.6M
EPS (Diluted)$-1.11$-2.31
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.0M$1.8M
Current Assets$307.0K$385.0K
Cash & Equivalents$29.0K$187.0K
Inventory$0$0
PP&E$235.0K$434.0K
Total Liabilities$11.0M$9.6M
Current Liabilities$11.0M$9.0M
Short-term Debt$967.0K$300.0K
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$10.0M-$7.8M
Retained Earnings-$236.9M-$226.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$7.0M-$9.1M
CapEx$0$0
Investing Cash Flow$0$12.0K
Financing Cash Flow$6.9M$8.0M
Dividends Paid$0$0
Net Change in Cash-$95.0K$0
Free Cash Flow$0$0

FAQ

What is BCLI P/E and revenue?

Brainstorm Cell Therapeutics Inc (BCLI) $11.4M cap.

What is BCLI revenue?

Brainstorm Cell Therapeutics Inc last cached revenue is $0 (FY2025).

Is BCLI profitable?

Brainstorm Cell Therapeutics Inc last cached net income is -$10.3M.

What are BCLI total assets?

Brainstorm Cell Therapeutics Inc last cached total assets are $1.0M.

What is BCLI free cash flow?

Brainstorm Cell Therapeutics Inc last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.